2022年全球及中国透明质酸增粘注射液行业头部企业市场占有率及排名调研报告
小羊咩咩丫丫2022-09-29 13:34
本文调研和分析全球透明质酸增粘注射液发展现状及未来趋势,核心内容如下:
(1)全球市场总体规模,分别按销量和按收入进行了统计分析,历史数据2017-2021年,预测数据2022至2028年。
(2)全球市场竞争格局,全球市场头部企业透明质酸增粘注射液销量、收入、价格市场占有率及行业排名,...查看全文
简介:Bioventus Inc.作为本次A类普通股的发行者,于2015年12月22日在特拉华州注册成立。Bioventus LLC作为一家有限责任公司于2011年11月23日在特拉华州成立。该公司是一家全球性医疗器械公司,致力于从浩如烟海的肌肉骨骼疾病患者的治疗中开发和创新的商业化专有生物性骨材产品。他们的产品满足不断增长的临床有效的需求,高性价比且微创的解决方案,增强人体的自然愈合过程。
今开: | 昨收: |
最高: | 最低: |
涨停价: | 跌停价: |
总市值:0 |
小羊咩咩丫丫2022-09-29 13:34
本文调研和分析全球透明质酸增粘注射液发展现状及未来趋势,核心内容如下:
(1)全球市场总体规模,分别按销量和按收入进行了统计分析,历史数据2017-2021年,预测数据2022至2028年。
(2)全球市场竞争格局,全球市场头部企业透明质酸增粘注射液销量、收入、价格市场占有率及行业排名,...查看全文
$Bioventus Inc. Class A Common Stock(BIOV)$ 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redee Filed: 2007-06-26 AccNo: 0001354457-07-000188 Size: 3 KB 网页链接
$Bioventus Inc. Class A Common Stock(BIOV)$ 8-K - Current report Filed: 2007-06-18 AccNo: 0001341004-07-001889 Size: 16 KBItem 8.01: Other Events 网页链接
$Bioventus Inc. Class A Common Stock(BIOV)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2007-07-26 AccNo: 0000950103-07-001919 Size: 35 KB 网页链接
$Bioventus Inc. Class A Common Stock(BIOV)$ AW - Amendment Withdrawal Request Filed: 2007-07-26 AccNo: 0000950103-07-001918 Size: 9 KB 网页链接
$Bioventus Inc. Class A Common Stock(BIOV)$ 15-12G - Securities registration termination [Section 12(g)] Filed: 2007-07-12 AccNo: 0000950103-07-001769 Size: 23 KB 网页链接
$Bioventus Inc. Class A Common Stock(BIOV)$ POS AM - Post-Effective amendments for registration statement Filed: 2007-07-12 AccNo: 0000950103-07-001768 Size: 35 KB 网页链接
$Bioventus Inc. Class A Common Stock(BIOV)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2007-07-06 AccNo: 0000950103-07-001740 Size: 95 KB 网页链接
$Bioventus Inc. Class A Common Stock(BIOV)$ 8-K - Current report Filed: 2007-06-26 AccNo: 0000950103-07-001642 Size: 43 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tr...
$Bioventus Inc. Class A Common Stock(BIOV)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2007-06-27 AccNo: 0000807249-07-000220 Size: 28 KB 网页链接
$Bioventus Inc. Class A Common Stock(BIOV)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2007-06-21 AccNo: 0000807249-07-000215 Size: 30 KB 网页链接